BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2583690)

  • 1. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
    Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
    Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
    Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
    Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
    Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
    J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: the effect of propranolol.
    Hilzenrat N; Arish A; Yaari A; Sikuler E
    J Gastroenterol Hepatol; 2001 Jul; 16(7):796-800. PubMed ID: 11446889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.
    Calès P; Braillon A; Girod C; Lebrec D
    J Hepatol; 1985; 1(4):349-57. PubMed ID: 4056347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosis.
    Desmorat H; Vinel JP; Lahlou O; Pipy B; Badia P; Cales P; Combis JM; Souqual MC; Pascal JP
    Hepatology; 1991 Jun; 13(6):1181-4. PubMed ID: 2050332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.
    Kravetz D; Bosch J; Arderiu M; Pilar Pizcueta M; Rodés J
    Hepatology; 1989 Jun; 9(6):808-14. PubMed ID: 2714733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Hepatology; 1985; 5(3):425-30. PubMed ID: 3922868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of flow and resistance in maintenance of portal hypertension in a rat model.
    Sikuler E; Groszmann RJ
    Am J Physiol; 1986 Feb; 250(2 Pt 1):G205-12. PubMed ID: 3953799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.
    Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D
    J Gastroenterol Hepatol; 1992; 7(5):449-54. PubMed ID: 1391726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats.
    Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM
    Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis.
    Gaiani S; Bolondi L; Fenyves D; Zironi G; Rigamonti A; Barbara L
    Hepatology; 1991 Nov; 14(5):824-9. PubMed ID: 1937388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
    Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in blood flow, portal pressure and shunting during the development of cirrhosis in response to beta-blockade.
    McLaren M; Braye S; Fleming J; Karran S; Taylor I
    Gut; 1987 Jun; 28(6):663-7. PubMed ID: 2887489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
    Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
    Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of portacaval surgical anastomosis on systemic and splanchnic hemodynamics in portal hypertensive, cirrhotic rats.
    Romeo JM; López-Farré A; Martín-Paredero V; López-Novoa JM
    Can J Physiol Pharmacol; 1988 Dec; 66(12):1493-8. PubMed ID: 3228783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
    Nevens F; Pizcueta MP; Fernández M; Bosch J; Rodés J
    Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
    Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
    J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.